← Open Payments lookup

STEPHANE SIA: Open Payments

NPI 1376963975 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,976 in 77 payments from 11 companies in 2025. Trend: 2023 $596 · 2024 $269 · 2025 $1,976

Food & beverage: $1,976
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc15$524
E.R. Squibb & Sons, L.L.C.13$266
Vanda Pharmaceuticals Inc.12$222
Teva Pharmaceuticals USA, Inc.10$218
Neurocrine BioSciences, Inc.6$154
Alkermes, Inc.6$143
Otsuka America Pharmaceutical, Inc.7$139
Axsome Therapeutics, Inc.1$125
ABBVIE INC.3$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74

Products named: INVEGA SUSTENNA, COBENFY, AUSTEDO XR, INGREZZA, ARISTADA, Auvelity, HETLIOZ, FANAPT.

Industry payments across MD — which companies pay providers there.